 |
 Video: What is a Stock Split?
|
|
|
| 10x Genomics is a life science technology company. Co.'s integrated platform solutions include instruments, consumables and software. Co.'s commercial product portfolio utilizes its Chromium X Series and Chromium Connect, its Visium CytAssist, an instrument designed to simplify the Visium solution workflow, its Xenium Analyzer, an instrument designed for high-throughput analysis of cells in their tissue environment, and its proprietary microfluidic chips, slides, reagents and other consumables for its Chromium, Visium and Xenium solutions. Co. bundles its software with these products to guide customers through the workflow, from sample preparation through analysis and visualization. According to our 10x Genomics stock split history records, 10x Genomics has had 0 splits. | |
|
10x Genomics (TXG) has 0 splits in our 10x Genomics stock split history database.
Looking at the 10x Genomics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into 10x Genomics shares, starting with a $10,000 purchase of TXG, presented on a split-history-adjusted basis factoring in the complete 10x Genomics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/13/2019 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$52.27 |
|
| End price/share: |
$27.52 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-47.35% |
|
| Average Annual Total Return: |
-12.97% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,266.06 |
|
| Years: |
4.62 |
|
|
|
|
|
